![Andrew Koven](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Koven
Président chez
METAVIA INC.
Fortune : 12 397 $ au 31/05/2026
Profil
Andrew Ian Koven is currently Chairman at MetaVia, Inc. since 2022, with employment at the firm starting in 2021.
Former roles include President, Director & Chief Administrative Officer at Neurologix, Inc. in 2011; Lead Independent Director at Kala Bio, Inc. from 2018 to 2026; Secretary, Executive VP & General Counsel at Sumitomo Pharma America, Inc. from 2007 to 2010; Associate General Counsel at Warner-Lambert Co. from 1993 to 2000; Secretary, Executive VP & General Counsel at KOS Pharmaceuticals, Inc. from 2003 to 2006; Chief Administrative & Legal Officer, Executive VP at Inspire Pharmaceuticals, Inc. from 2010 to 2011; President & Chief Business Officer at POZEN, Inc. from 2015 to 2016; Secretary, CAO, Executive VP & General Counsel at Auxilium Pharmaceuticals LLC from 2012 to 2015; Associate at Cahill Gordon & Reindel LLP from 1986 to 1992; Senior Vice President & General Counsel at Lavipharm Corp.
from 2000 to 2003; Counsel-Corporate & Investment Division at Equitable Financial Life Insurance Co. from 1992 to 1993; Secretary, Senior Vice President & General Counsel at Lavipharm Laboratories, Inc. from 2000 to 2003; President & Chief Business Officer at Old API Wind-down Ltd. from 2015 to 2019; and President & Chief Business Officer at Aralez Pharmaceuticals Plc.
Education includes undergraduate and graduate degrees from Dalhousie University conferred in 1978 and 1981, respectively, and a graduate degree from Columbia Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
METAVIA INC. 0,08 % | 08/06/2026 | 4 153 ( 0,08 % ) | 11 795 $ | 31/05/2026 |
| 29/12/2025 | 270 ( 0 % ) | 602 $ | 31/05/2026 |
Postes actifs de Andrew Koven
| Sociétés | Poste | Début |
|---|---|---|
| METAVIA INC. | Président | 14/01/2022 |
Anciens postes connus de Andrew Koven
| Sociétés | Poste | Fin |
|---|---|---|
| KALA BIO, INC. | Directeur/Membre du Conseil | 30/01/2026 |
| OLD API WIND-DOWN LTD. | President | 31/01/2019 |
Aralez Pharmaceuticals Plc
 Aralez Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company focused on transforming medicines that can transform lives | President | 01/01/2019 |
| POZEN INC. | President | 01/02/2016 |
| AUXILIUM PHARMACEUTICALS, INC. | Directeur Administratif | 01/01/2015 |
Formation de Andrew Koven
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
Neurologix, Inc.
 Neurologix, Inc. Internet Software/ServicesTechnology Services Develops therapies for the brain and central nervous system | Technology Services |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Cahill Gordon & Reindel LLP
 Cahill Gordon & Reindel LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Lavipharm Corp.
 Lavipharm Corp. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical & cosmetic products | Health Technology |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Equitable Financial Life Insurance Co.
 Equitable Financial Life Insurance Co. Investment Trusts/Mutual FundsMiscellaneous Functions as a unit investment trust | Miscellaneous |
Lavipharm Laboratories, Inc. | |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aralez Pharmaceuticals Plc
Aralez Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company focused on transforming medicines that can transform lives | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
NeuroBo Pharmaceuticals, Inc.
 NeuroBo Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops disease-modifying therapies for neurodegenerative diseases | Health Technology |
